Q32 Bio (QTTB) Debt Ratio (2023 - 2026)
Q32 Bio (QTTB) recorded quarterly Debt Ratio of 0.13 in Q1 2026, down 18.27% quarter-over-quarter from 0.16 in Q4 2025, and down 20.04% on a YoY basis from 0.16 in Q1 2025.
Q32 Bio (QTTB) Debt Ratio (2023 - 2026) Analysis & Trends
Q32 Bio's Debt Ratio history runs 4 years deep, the most recent figure standing at 0.13 for Q1 2026.
- In Q1 2026, Debt Ratio fell 20.04% year-over-year to 0.13; the TTM figure through Mar 2026 stood at 0.13 (down 20.04% YoY), while the FY2025 annual figure was 0.16, up 14.67% from the prior year.
- Debt Ratio was 0.13 for Q1 2026 at Q32 Bio, down from 0.16 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.19 in Q3 2025 to a low of 0.08 in Q1 2024.
- Historically, Debt Ratio has averaged 0.14 across 4 years, with a median of 0.13 in 2024.
- The sharpest annual moves came in 2025 and 2026: Debt Ratio surged 95.94% in 2025, then retreated 20.04% in 2026.
- A 4-year view of Debt Ratio shows it stood at 0.12 in 2023, then grew by 18.13% to 0.14 in 2024, then advanced by 14.67% to 0.16 in 2025, then retreated by 18.27% to 0.13 in 2026.
- The last three Debt Ratio figures came in at 0.13 (Q1 2026), 0.16 (Q4 2025), and 0.19 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.18 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Q32 Bio | 167.59 Mn | 116.84 Mn | - | 0.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.13 |
| Dec 31, 2025 | 0.16 |
| Sep 30, 2025 | 0.19 |
| Jun 30, 2025 | 0.19 |
| Mar 31, 2025 | 0.16 |
| Dec 31, 2024 | 0.14 |
| Sep 30, 2024 | 0.12 |
| Jun 30, 2024 | 0.10 |
| Mar 31, 2024 | 0.08 |
| Dec 31, 2023 | 0.12 |